Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Clinical Efficacy and Safety of Specific Mode Electroacupuncture Stimulation for Paclitaxel Across BBB Delivery in Patients With Postoperative Recurrence of Malignant Glioma: A Single-arm Trial

NCT06818331 is registered in ClinicalTrials.gov with The Third Affiliated hospital of Zhejiang Chinese Medical University as lead sponsor.

NCT NCT06818331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06818331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Clinical Efficacy and Safety of Specific Mode Electroacupuncture Stimulation for Paclitaxel Across BBB Delivery in Patients With Postoperative Recurrence of Malignant Glioma: A Single-arm Trial
Lead sponsor
The Third Affiliated hospital of Zhejiang Chinese Medical University
Phase
Phase 2
Overall status
Recruiting
Start date
February 10, 2025
Completion date
February 24, 2028
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioma